Subscribe to out newsletter today to receive latest news.

Let’s Stay In Touch

crizotinib spc

crizotinib spc
£1,700.00

Crizonix contains the cancer drug Crizotinib, a kinase inhibitor indicated in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive or ROS 1 positive

Crizotinib spc

Crizotinib spc contains the cancer drug Crizotinib, a kinase inhibitor indicated in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive or ROS 1 positive. Crizotinib is FDA-approved as a therapy for both ALK-positive and ROS1-positive metastatic NSCLC. It is the only FDA-approved drug for ROS 1-positive NSCLC.

Dosage and Administration
Each pack of crizotinib spc contains 28 x 250mg capsules.

Your doctor will prescribe you a specific dose. Your doctor should also advise how often to take Crizotinib, when to take Crizotinib and how long to take Crizotinib.

Precautions
Crizonix can be used by:

  • adults with ALK-positive advanced NSCLC (non-small cell lung cancer)
  • adults with previously treated ALK-positive advanced NSCLC & ROS1 (+) NSCLC

Interaction

CYP3A Inhibitors: Concurrent use of crizotinib spc avoided with strong CYP3A inhibitors including but not limited to atazanavir, clarithromycin, indinavir, itraconazole, ketoconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, troleandomycin, and voriconazole

CYP3A Inducers: Use of crizotinib spc should avoid with strong CYP3A inducers, including but not limited to carbamazepine, phenobarbital, phenytoin, rifabutin, rifampin, and St. John’s Wort

The most common adverse reactions (≥25%) are vision disorders, nausea, diarrhea, vomiting, edema, constipation, elevated transaminases, fatigue, decreased appetite, upper respiratory infection, dizziness, and neuropathy.

Let's chat on WhatsApp

Welcome to Mic Jeffon Pharmacy How can we help you? :)

00:25